TrialClinical cancer research : an official journal of the American Association for Cancer Research2011

Gefitinib or placebo in combination with tamoxifen in patients with hormone receptor-positive metastatic breast cancer: a randomized phase II study.

C Kent Osborne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.